FUNCTIONAL SINGLE VENTRICLE HEART DISEASE

Clinical trials for FUNCTIONAL SINGLE VENTRICLE HEART DISEASE explained in plain language.

Never miss a new study

Get alerted when new FUNCTIONAL SINGLE VENTRICLE HEART DISEASE trials appear

Sign up with your email to follow new studies for FUNCTIONAL SINGLE VENTRICLE HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Year-Long heart drug safety test for fontan teens shows promise

Disease control Completed

This study followed 301 adolescents with single ventricle heart disease who had previously undergone Fontan surgery to assess the long-term safety of taking udenafil medication for one year. Participants took udenafil daily while researchers monitored for side effects and measure…

Matched conditions: FUNCTIONAL SINGLE VENTRICLE HEART DISEASE

Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control

Last updated Apr 04, 2026 08:20 UTC

FUNCTIONAL SINGLE VENTRICLE HEART DISEASE

Get alerted when new FUNCTIONAL SINGLE VENTRICLE HEART DISEASE trials appear

Year-Long heart drug safety test for fontan teens shows promise